EGFR and Alzheimer disease: Extending causal mapping to neuroimaging, Wang et al. combined brain and plasma proteomics with imaging GWASs to implicate more than 300 proteins in brain structural traits and highlighted EGFR and TMEM106B in white-matter pathways connected to AD risk [23].